Concepedia

Dallas Williams

DW

12

Publications

1.3K

Citations

12

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dallas Williams is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacotherapy, cancer therapeutics, and oncology.

Top concepts

Publications per year

2001–2012

12

Publications

12

Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study

Lance C. Pagliaro, Dallas Williams, Danai Daliani et al. · Journal of Clinical Oncology · 2010 · 386 citations · Full text

Integrated Therapy for Locally Advanced Bladder Cancer: Final Report of a Randomized Trial of Cystectomy Plus Adjuvant M-VAC Versus Cystectomy With Both Preoperative and Postoperative M-VAC

Randall E. Millikan, Colin P. Dinney, David A. Swanson et al. · Journal of Clinical Oncology · 2001 · 268 citations

Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer

Arlene O. Siefker‐Radtke, Ashish M. Kamat, H. Barton Grossman et al. · Journal of Clinical Oncology · 2009 · 170 citations · Full text

Repeated Intravesical Instillations of an Adenoviral Vector in Patients With Locally Advanced Bladder Cancer: A Phase I Study of <i>p53</i> Gene Therapy

Lance C. Pagliaro, Afsaneh Keyhani, Dallas Williams et al. · Journal of Clinical Oncology · 2003 · 132 citations

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer

Arlene O. Siefker‐Radtke, Colin P. Dinney, Yu Shen et al. · Cancer · 2012 · 81 citations · Full text

Rows per page

1–5 of 12